Last updated: July 8, 2026

Anthem Florida Weight Loss Treatment Coverage | Klarity Health

Anthem plans in Florida — including Florida Blue (Blue Cross Blue Shield of Florida) — may cover weight loss treatment, including prescription GLP-1 medications and obesity management services, depending on your specific plan, formulary, prior authorization requirements, and medical necessity documentation. Klarity Health offers online weight loss treatment in Florida, with 2,000+ licensed providers available to evaluate your eligibility and assist with medication management. Coverage is not guaranteed and varies by plan.

Check if your Anthem plan may cover weight loss treatment at Klarity →

Florida Parity Laws and Weight Loss Treatment

Florida law provides important protections for patients seeking treatment for obesity and weight-related conditions. Understanding these statutes can help you determine what coverage your Anthem or Florida Blue plan may be required to provide.

• Florida Statute § 627.6574 (individual plans): Requires individual health insurance policies in Florida to provide mental health and substance use disorder benefits that are comparable to medical and surgical benefits. Binge Eating Disorder (BED) — classified as a DSM-5 eating disorder — may qualify for parity protections under this statute, potentially requiring coverage equal to that provided for comparable medical conditions.
• Florida Statute § 627.6578 (group plans): Applies the same parity requirements to group health plans in Florida. Employer-sponsored Anthem and Florida Blue group plans are subject to this statute, unless they are ERISA self-funded plans (which are governed by federal MHPAEA instead). ERISA self-funded plans may carve out state parity mandates but remain subject to federal parity law.
• Florida Statute § 627.42397 (telehealth parity): Requires insurers to cover telehealth services on the same basis as in-person services when clinically appropriate. This statute may support coverage for online weight loss consultations and GLP-1 medication management through platforms like Klarity Health. Insurers may not impose separate cost-sharing or benefit limitations solely because care is delivered via telehealth.
• Federal MHPAEA: The Mental Health Parity and Addiction Equity Act requires that coverage for mental health and eating disorders (including BED) not be more restrictive than coverage for comparable medical or surgical conditions. MHPAEA applies to most employer-sponsored plans and complements Florida’s state parity statutes.

Binge Eating Disorder (BED) and Parity

Binge Eating Disorder is classified in the DSM-5 as a mental health condition. Under Florida §§ 627.6574 and 627.6578, and federal MHPAEA, treatment for BED — including behavioral therapy and, in some cases, medication — may be subject to parity protections. Patients seeking weight loss treatment who also have a BED diagnosis may have access to a broader range of covered services. Verify the specific coverage terms with Florida Blue or your employer’s HR benefits team.

ACA Section 2713: Preventive Obesity Counseling

Under the Affordable Care Act (ACA), most non-grandfathered health plans are required to cover intensive behavioral counseling for obesity — as recommended by the U.S. Preventive Services Task Force (USPSTF) — without cost-sharing. This may include in-person or telehealth counseling sessions focused on diet, physical activity, and behavioral change. Note that ACA preventive coverage requirements do not mandate coverage of prescription weight loss medications; GLP-1 coverage depends on plan-specific pharmacy benefits and medical necessity criteria.

Florida Statute § 456.44 and EPCS: What Weight Loss Patients Should Know

Florida Statute § 456.44 requires practitioners to use an Electronic Prescription for Controlled Substances (EPCS) system when prescribing Schedule II controlled substances via telehealth. For weight loss treatment, this distinction matters:

• Phentermine: A Schedule IV controlled substance — NOT Schedule II. Florida’s EPCS mandate under § 456.44 does not apply to phentermine. Providers may prescribe phentermine via telehealth without EPCS-specific requirements, though standard telehealth prescribing rules apply.
• Qsymia (phentermine/topiramate ER): Schedule IV, subject to FDA REMS program. Not subject to Florida § 456.44 EPCS mandate, but REMS requirements apply regardless of prescribing channel.
• GLP-1 medications (Wegovy, Saxenda, Zepbound): Non-controlled substances. No EPCS requirement. Standard telehealth prescribing applies.
• Contrave (bupropion/naltrexone): Non-controlled. No EPCS requirement.

This contrasts with ADHD treatment, where first-line stimulants (Adderall, Vyvanse, Ritalin) are Schedule II and subject to the full § 456.44 EPCS mandate. Weight loss telehealth prescribing faces fewer controlled substance restrictions than ADHD telehealth prescribing in Florida.

Florida Blue Plan Types and Weight Loss Coverage

Anthem operates in Florida primarily through Florida Blue (Blue Cross Blue Shield of Florida). Florida Blue offers three main plan types, each with different coverage structures for weight loss treatment:

• Blue Options PPO: Offers flexibility to see in-network and out-of-network providers, including telehealth providers like Klarity Health, without a referral. Weight loss benefits, formulary access, and cost-sharing depend on the specific plan design selected by you or your employer.
• Blue Select HMO: Requires care through Florida Blue’s HMO network and in most cases requires a primary care referral before seeing a specialist for obesity management. In-network telehealth may be covered. Verify whether Klarity Health providers are in-network under your specific HMO plan.
• BlueSelect Plus EPO / HDHP: EPO plans require in-network care with no out-of-network benefits (except emergencies). HDHP plans typically have higher deductibles and may be paired with Health Savings Accounts (HSAs). See HDHP/HSA section below for implications for weight loss medication costs.

CVS/Caremark: Florida Blue’s PBM as of January 1, 2026

Effective January 1, 2026, Florida Blue switched its pharmacy benefit manager (PBM) from Prime Therapeutics to CVS/Caremark. All pharmacy benefit claims, formulary determinations, prior authorizations for medications, and specialty pharmacy services for Florida Blue members are now processed through CVS/Caremark.

Contact CVS/Caremark for formulary questions or prior authorization status: 1-866-278-5108.

CVS/Caremark GLP-1 Formulary for Weight Loss (2026)

Formulary status and tier placement may vary by specific Florida Blue plan. Verify your plan’s drug formulary at floridablue.com or by calling CVS/Caremark at 1-866-278-5108. Coverage is not guaranteed.

CVS/Caremark Wegovy Prior Authorization Criteria

CVS/Caremark generally requires all of the following for Wegovy approval:

• Patient is 18 years of age or older (or 12–17 for Wegovy injection under pediatric criteria)
• Patient has participated in a comprehensive weight management program (behavioral modification, reduced-calorie diet, and increased physical activity) with continuing follow-up for at least 6 months prior to drug therapy
• Patient meets one of: BMI ≥30 kg/m², OR BMI ≥27 kg/m² with at least one weight-related comorbidity (e.g., hypertension, type 2 diabetes, dyslipidemia)
• Medication to be used in combination with a reduced-calorie diet and increased physical activity
• No concurrent use of other semaglutide-containing products or other GLP-1 receptor agonists

Documentation of BMI, comorbidities, and prior weight management program participation is required for approval. Klarity’s clinical team may assist with gathering and submitting this documentation.

Oral Weight Loss Medications Under CVS/Caremark

HDHP and HSA Considerations

If your Florida Blue plan is a High Deductible Health Plan (HDHP) paired with a Health Savings Account (HSA), weight loss treatment costs may count toward your deductible before coverage applies. In 2026, IRS minimum HDHP deductibles are $1,650 for self-only coverage and $3,300 for family coverage.

Under the ACA’s Section 2713 preventive care exception, USPSTF-recommended obesity counseling must be covered without cost-sharing even on HDHPs, because it qualifies as preventive care. However, prescription GLP-1 medications (Wegovy, Saxenda) are not classified as preventive services and are subject to your deductible and cost-sharing before HDHP coverage applies.

HSA funds may be used to pay for weight loss treatment costs — including prescription medications, provider visits, and deductible-applicable expenses — if prescribed for a diagnosed medical condition (obesity). Over-the-counter weight loss supplements generally do not qualify as HSA-eligible expenses. Consult a tax advisor or your plan documents for specific HSA eligibility guidance.

Florida Medicaid and the Coverage Gap

Florida has not expanded Medicaid under the ACA. Adults without dependents typically do not qualify for Florida Medicaid regardless of income. This creates a coverage gap for many low-income Floridians who do not qualify for Medicaid but cannot afford private insurance. Patients in this gap may have limited or no insurance coverage for weight loss treatment.

For uninsured or underinsured patients, GoodRx may reduce costs for generic phentermine and some other oral weight loss medications. Manufacturer patient assistance programs (see below) may also help with branded GLP-1 costs.

Patient Assistance Programs (PAPs)

• NovoCare (Wegovy / Saxenda — Novo Nordisk): Patients without insurance coverage or whose plan does not cover Wegovy or Saxenda may qualify for NovoCare patient assistance. Eligibility is income-based. Visit novonordisk-us.com/products/novocare.html or call 1-833-NOVO-411 for details.
• LillyAssist (Zepbound — Eli Lilly): Because CVS/Caremark removed Zepbound from its formulary effective July 1, 2025, patients whose Florida Blue plan uses CVS/Caremark may be unable to obtain Zepbound through insurance. LillyAssist provides income-based assistance for eligible patients. Visit lilly.com/patient-assistance-support/lillyassist or call 1-800-545-5979.

How Klarity Health Works for Weight Loss Treatment in Florida

1. Check if your plan may cover care: Use Klarity’s benefits verification tool to see if your Florida Blue or Anthem plan may cover weight loss treatment at Klarity. Coverage is not guaranteed — verify your specific plan benefits before booking.
2. Book a consultation: Schedule with one of Klarity’s 2,000+ licensed providers. Providers are available via telehealth throughout Florida.
3. Clinical evaluation: Your provider will assess your weight history, BMI, comorbidities, and prior weight management efforts. This evaluation generates the documentation needed for prior authorization if a GLP-1 medication is clinically appropriate.
4. Prescription and prior authorization support: If Wegovy or another covered medication is recommended, Klarity’s team may assist with the prior authorization submission to CVS/Caremark. PA timelines vary.
5. Ongoing management: Weight loss treatment typically requires ongoing follow-up visits to monitor progress, adjust dosing, and support long-term outcomes.

See if you may qualify for weight loss treatment at Klarity →

Frequently Asked Questions

Does Anthem cover weight loss treatment in Florida?

Anthem operates in Florida through Florida Blue (Blue Cross Blue Shield of Florida). Florida Blue plans may cover weight loss treatment — including prescription medications and medical obesity management — depending on your specific plan, formulary, and medical necessity documentation. Coverage varies by plan and is not guaranteed. Verify your benefits with Florida Blue (1-800-352-2583) or through Klarity’s benefits check before booking.

Does Florida Blue cover Wegovy in 2026?

Some Florida Blue plans may cover Wegovy (semaglutide) for weight loss, subject to CVS/Caremark formulary inclusion, prior authorization, and medical necessity criteria. CVS/Caremark generally requires BMI ≥30 (or BMI ≥27 with a weight-related comorbidity) and documentation of a 6-month prior weight management program. Coverage is not guaranteed and varies by plan. Check your specific plan’s drug formulary at floridablue.com or call CVS/Caremark at 1-866-278-5108.

Is Zepbound covered by Florida Blue in 2026?

CVS/Caremark — which became Florida Blue’s PBM on January 1, 2026 — removed Zepbound (tirzepatide for weight loss) from its formulary effective July 1, 2025. As a result, most Florida Blue plans using CVS/Caremark do not cover Zepbound for weight loss in 2026. Patients may request a formulary exception or explore the LillyAssist patient assistance program. Contact CVS/Caremark at 1-866-278-5108 to confirm coverage for your specific plan.

What is the prior authorization process for GLP-1 medications with Florida Blue?

Prior authorization for GLP-1 medications (such as Wegovy) through CVS/Caremark typically requires BMI documentation, evidence of a prior comprehensive weight management program (at least 6 months), and documentation of any weight-related comorbidities. Your Klarity provider can help generate and organize the clinical documentation needed for the PA submission. PA decisions are made by CVS/Caremark and timelines vary. Coverage is not guaranteed.

Does Florida parity law require coverage of weight loss treatment?

Florida’s parity statutes (§§ 627.6574 and 627.6578) require mental health benefits to be comparable to medical benefits. These statutes may support coverage of Binge Eating Disorder (BED) treatment, which can intersect with obesity and weight management. However, Florida law does not specifically mandate coverage of prescription GLP-1 medications. Coverage of weight loss medications depends on your plan’s pharmacy benefits and formulary. ERISA self-funded employer plans are governed by federal MHPAEA rather than Florida state parity statutes.

Does phentermine require an electronic prescription in Florida?

No. Florida Statute § 456.44 requires electronic prescriptions (EPCS) only for Schedule II controlled substances. Phentermine is a Schedule IV controlled substance — it is not subject to Florida’s EPCS mandate. Providers may prescribe phentermine via telehealth without EPCS-specific requirements, though standard telehealth prescribing rules and DEA registration apply. This is different from ADHD stimulants (Adderall, Ritalin), which are Schedule II and require EPCS in Florida.

Is Klarity Health in-network with Florida Blue?

Klarity Health works with many insurance plans in Florida. In-network status with Florida Blue depends on your specific plan type (Blue Options PPO, Blue Select HMO, or BlueSelect Plus EPO/HDHP) and your provider. Use Klarity’s benefits verification tool or contact Florida Blue member services at 1-800-352-2583 to confirm in-network status before your first appointment.

How do I appeal a denied prior authorization for Wegovy with Florida Blue?

If your prior authorization for Wegovy is denied by CVS/Caremark, you have the right to appeal. Submit a written appeal with additional clinical documentation — including updated BMI measurements, comorbidity records, and evidence of prior weight management program participation — through CVS/Caremark’s appeals process. Your Klarity provider can assist with documentation. You may also contact the Florida Office of Insurance Regulation at 1-877-693-5236 if you believe your rights under Florida insurance law have been violated.

Disclaimer: Klarity Health is independent from Florida Blue, Anthem, Elevance Health, and CVS/Caremark. Insurance coverage varies by plan, insurer, and individual circumstances. The information on this page is intended as general guidance only and does not constitute a guarantee of benefits or coverage. Formulary status and prior authorization criteria are subject to change. Telehealth provider availability may vary by state. Always verify your specific plan’s benefits with your insurer or through Klarity’s benefits verification tool before booking. This page reflects publicly available information as of July 2026.

Check if your plan may cover weight loss treatment at Klarity →